首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1917756

女性健康設備市場－2026-2031年預測

Women's Health Devices Market - Forecast from 2026 to 2031

出版日期: 2026年01月05日 | 出版商:

Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計女性健康設備市場將從 2025 年的 407.74 億美元成長到 2031 年的 644.34 億美元，複合年成長率為 7.92%。

女性健康設備市場透過先進的診斷和監測技術，應對日益增多的乳癌和卵巢癌病例。旨在改善健康狀況的全球宣傳宣傳活動和教育措施正在推動市場成長。此外，該市場也致力於解決老年女性罹患慢性病和生殖系統疾病的風險日益增加的問題。針對女性特定醫療保健解決方案的大量投資和創新正在推動該市場的進一步發展。

女性健康設備旨在診斷、監測和治療女性特有或常見的疾病，例如乳癌和卵巢癌等婦科疾病。這些疾病發生率的上升趨勢，以及女性人口的成長和健康意識的提高，是推動該市場成長要素。

成長要素是女性特有的各種健康問題的日益增加。女性面臨不成比例的風險，包括性健康和生殖健康的併發症。例如，根據世界衛生組織2023年的報告，在實行女性生殖器切割（FGM）的地區，將有超過2億女孩和婦女遭受這種殘害。

乳癌和卵巢癌發生率的不斷上升顯著推動了對相關設備的需求。根據世界癌症研究基金會（WCRF）統計，卵巢癌是全球女性第八大常見癌症。這些惡性腫瘤凸顯了專業診斷和篩檢設備在早期發現和治療中的重要性。

老年女性人口的不斷成長也是推動市場發展的重要因素，因為她們更容易罹患糖尿病和卵巢癌等疾病。根據美國國家生物技術資訊中心（NCBI）估計，到2025年，全球老年女性人口預計將達到約6.04億，這將進一步增加對標靶醫療設備的需求。

多項宣傳活動正在促進女性健康素養的提升和醫療器材的普及。由北卡羅來納州人類研究與社區參與辦公室 (OHRCE)、臨床研究委員會 (CRB) 和國家環境健康科學研究所 (NIEHS) 等機構主導的北卡羅來納州女性健康意識 (WHA) 社區參與項目，就是一個推進研究和提高公眾意識的良好範例。

鑑於上述成長要素，市場准入和擴張的機會巨大。世界經濟論壇在2023年1月指出，對女性專案研究進行約3億美元的重點投資，可透過降低醫療成本、提高生活品質和提升勞動生產力，創造130億美元的經濟回報。政府措施、宣傳宣傳活動和以投資為重點的會議預計將對該領域產生積極影響。

從地理上看，由於乳癌高發生，預計北美將在預測期內佔據顯著的市場佔有率。根據美國癌症協會統計，乳癌占美國女性新發癌症病例的30%，預計2023年新增侵襲性乳癌病例將達297,790例。女性勞動參與率的提高以及相對於男性收入的成長，推動了個人醫療保健支出的增加，進而促進了醫療設備的使用。

女性健康醫療器材領域的主要企業包括GE醫療集團，這是一家全球領先的醫藥診斷、數位化解決方案和醫療技術供應商。該公司旗下的Voluson®女性健康超音波產品線涵蓋了許多先進系統，例如具備先進影像功能的Voluson® Expert系列，以及專為產科、婦科和輔助生殖技術設計的Voluson® Performance。總部位於美國的女性健康醫療器材專家Caldera Medical致力於透過其產品提升醫療照護標準，例如用於治療壓力性尿失禁的Desara®系統、用於骶骨陰道固定術的Vertessa®系統以及用於治療難治性宮底和角膜組織穿刺的Benesta®系統。 Hologic是女性健康領域的知名企業，專注於乳房、婦科、性健康、身體組成和骨骼健康，並提供諸如3Dimensions®乳房X光攝影系統和用於改善乳房健康篩檢的3DQuorum™成像技術等解決方案。

總體而言，在人口結構變化、疾病負擔、宣傳活動以及針對女性醫療保健領域未滿足需求的創新措施的推動下，市場預計將穩定成長。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2021-2025 年）和預測資料（2026-2031 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

The women's health devices market is addressing escalating cases of breast and ovarian cancer through advanced diagnostic and monitoring technologies. Growth is supported by global awareness campaigns and educational initiatives aimed at improving health outcomes. The market is also catering to an aging female population with heightened vulnerability to chronic and reproductive conditions. Significant investments and innovations targeted at female-specific healthcare solutions are driving further advancement.

Women's health devices are specifically engineered to diagnose, monitor, and treat conditions unique to or predominant in women, including breast and ovarian cancers as well as broader gynecologic health issues. The rising prevalence of these illnesses, combined with an expanding female population and heightened health awareness, constitutes primary growth drivers for the market.

Key growth factors include the multitude of women-associated health concerns with elevated incidence rates. Women face disproportionate risks in areas such as sexual and reproductive health complications. For instance, more than 200 million girls and women worldwide have undergone female genital mutilation (FGM) in practicing regions as reported by the WHO in 2023.

The increasing prevalence of breast and ovarian cancers significantly augments demand. Ovarian cancer ranks as the 8th most common cancer in women globally according to the World Cancer Research Fund (WCRF). These malignancies underscore the critical role of specialized diagnostic and screening devices in early detection and management.

An expanding elderly female population further propels the market, as older women are more susceptible to conditions like diabetes and ovarian cancer. Projections indicate approximately 604 million elderly women worldwide by 2025 per NCBI estimates, amplifying the need for targeted health devices.

Multiple awareness programs enhance women's health literacy and device adoption. Initiatives led by organizations such as the Office of Human Research and Community Engagement (OHRCE), Clinical Research Branch (CRB), and National Institute of Environmental Health Sciences (NIEHS) through the Women's Health Awareness (WHA) Community Engagement Programme in North Carolina exemplify efforts to promote research and advocacy.

Opportunities for market entry and expansion are substantial, driven by the aforementioned growth factors. Recognition at the World Economic Forum in January 2023 highlighted that targeted investments of around $300 million in women-specific research could yield $13 billion in economic returns through healthcare savings, improved quality of life, and enhanced workforce productivity. Government efforts, awareness campaigns, and investment-focused conferences are expected to positively influence the sector.

Geographically, North America is projected to secure a significant market share during the forecast period. Contributing elements include high breast cancer incidence, with the disease accounting for 30% of all new female cancer cases in the US according to the American Cancer Society, and approximately 297,790 new invasive cases estimated in 2023. Rising female workforce participation and increasing earnings relative to men enable greater personal health expenditure, further bolstering device uptake.

Leading companies in the women's health devices arena include GE Healthcare, a global provider of pharmaceutical diagnostics, digital solutions, and medical technology. The company's Voluson Women's Health Ultrasound portfolio spans advanced systems like the Voluson(TM) Expert Series for progressive imaging capabilities and Voluson(TM) Performance tailored for obstetrics, gynecology, and assisted reproductive medicine. Caldera Medical, a US-based specialist in women's health devices, focuses on elevating standards of care with products such as Desara(R) for stress urinary incontinence, Vertessa(R) for sacrocolpopexy procedures, and the Benesta(R) System for accessing challenging fundal and corneal tissue. Hologic, a prominent women's health company, emphasizes breast, gynecologic, sexual, body composition, and skeletal health, offering solutions like the 3Dimensions(R) Mammography System and 3DQuorum(TM) Imaging Technology for enhanced breast health diagnostics.

Overall, the market is poised for steady growth, fueled by demographic shifts, disease burden, awareness initiatives, and targeted innovations that address unmet needs in female-specific healthcare.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Women's Health Devices Market Segmentation

By Application
Cancer
Osteoporosis
Infectious Disease
Uterine Fibroids
Post-menopausal Syndrome
Pregnancy
Female Sterilization
Other
By End-User
Hospitals
Obstetrics & Gynecology Clinics
Diagnostic Laboratories
Ambulatory Surgical Centers
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. WOMEN'S HEALTH DEVICES MARKET BY APPLICATION

5.1. Introduction
5.2. Cancer
5.3. Osteoporosis
5.4. Infectious Disease
5.5. Uterine Fibroids
5.6. Post-menopausal Syndrome
5.7. Pregnancy
5.8. Female Sterilization
5.9. Other

6. WOMEN'S HEALTH DEVICES MARKET BY END-USER

6.1. Introduction
6.2. Hospitals
6.3. Obstetrics & Gynecology Clinics
6.4. Diagnostic Laboratories
6.5. Ambulatory Surgical Centers

7. WOMEN'S HEALTH DEVICES MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. USA
- 7.2.2. Canada
- 7.2.3. Mexico
7.3. South America
- 7.3.1. Brazil
- 7.3.2. Argentina
- 7.3.3. Others
7.4. Europe
- 7.4.1. Germany
- 7.4.2. France
- 7.4.3. United Kingdom
- 7.4.4. Spain
- 7.4.5. Others
7.5. Middle East and Africa
- 7.5.1. Saudi Arabia
- 7.5.2. UAE
- 7.5.3. Others
7.6. Asia Pacific
- 7.6.1. China
- 7.6.2. India
- 7.6.3. Japan
- 7.6.4. South Korea
- 7.6.5. Indonesia
- 7.6.6. Thailand
- 7.6.7. Others